PAMELA BROCK: Open Payments
NPI 1205235140 · CRESTVIEW HILLS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,437 in 75 payments from 15 companies in 2025. Trend: 2023 $569 · 2024 $574 · 2025 $1,437
Food & beverage: $1,437
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $173 |
| AstraZeneca Pharmaceuticals LP | 8 | $169 |
| Amgen Inc. | 11 | $162 |
| Calliditas Therapeutics US Inc. | 7 | $156 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $106 |
| Vifor Pharma, Inc. | 5 | $106 |
| Ardelyx, Inc. | 5 | $100 |
| Fresenius USA Marketing, Inc. | 4 | $95 |
| Travere Therapeutics, Inc. | 5 | $85 |
Products named: Kerendia, FARXIGA, TARPEYO, KRYSTEXXA, JARDIANCE, Veltassa, IBSRELA, VELPHORO.
Industry payments across KY — which companies pay providers there.
